JP5464730B2 - Whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer and hair papillary cell proliferation promoter - Google Patents
Whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer and hair papillary cell proliferation promoter Download PDFInfo
- Publication number
- JP5464730B2 JP5464730B2 JP2009087634A JP2009087634A JP5464730B2 JP 5464730 B2 JP5464730 B2 JP 5464730B2 JP 2009087634 A JP2009087634 A JP 2009087634A JP 2009087634 A JP2009087634 A JP 2009087634A JP 5464730 B2 JP5464730 B2 JP 5464730B2
- Authority
- JP
- Japan
- Prior art keywords
- hair
- hot water
- promoter
- extract
- water extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004209 hair Anatomy 0.000 title claims description 43
- 108020004999 messenger RNA Proteins 0.000 title claims description 29
- 230000002087 whitening effect Effects 0.000 title claims description 26
- 230000003712 anti-aging effect Effects 0.000 title claims description 23
- 230000004663 cell proliferation Effects 0.000 title description 15
- 239000000284 extract Substances 0.000 claims description 64
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 64
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 45
- 239000003795 chemical substances by application Substances 0.000 claims description 36
- 238000004519 manufacturing process Methods 0.000 claims description 27
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 27
- 108010024636 Glutathione Proteins 0.000 claims description 22
- 229960003180 glutathione Drugs 0.000 claims description 22
- 230000009471 action Effects 0.000 claims description 15
- 230000008099 melanin synthesis Effects 0.000 claims description 15
- 230000010261 cell growth Effects 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 13
- 239000001384 succinic acid Substances 0.000 claims description 13
- 230000002401 inhibitory effect Effects 0.000 claims description 11
- 108700041153 Filaggrin Proteins Proteins 0.000 claims description 10
- 239000007952 growth promoter Substances 0.000 claims description 10
- 210000004027 cell Anatomy 0.000 description 40
- 239000000523 sample Substances 0.000 description 35
- 230000001737 promoting effect Effects 0.000 description 27
- 238000000605 extraction Methods 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 238000002835 absorbance Methods 0.000 description 13
- 238000012360 testing method Methods 0.000 description 12
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
- 239000012091 fetal bovine serum Substances 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 210000000434 stratum corneum Anatomy 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 230000002500 effect on skin Effects 0.000 description 9
- 230000003779 hair growth Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000002994 raw material Substances 0.000 description 8
- 102100028314 Filaggrin Human genes 0.000 description 7
- 101710088660 Filaggrin Proteins 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 208000001382 Experimental Melanoma Diseases 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 238000004811 liquid chromatography Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 208000012641 Pigmentation disease Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000012264 purified product Substances 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000031774 hair cycle Effects 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000218645 Cedrus Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229930004069 diterpene Natural products 0.000 description 2
- 125000000567 diterpene group Chemical group 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- -1 flavanone glycoside Chemical class 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 108010075526 keratohyalin Proteins 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000013076 target substance Substances 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010053070 Glutathione Disulfide Proteins 0.000 description 1
- 108010063907 Glutathione Reductase Proteins 0.000 description 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 241000133134 Saussurea Species 0.000 description 1
- 235000005158 Thymus praecox ssp. arcticus Nutrition 0.000 description 1
- 240000006001 Thymus serpyllum Species 0.000 description 1
- 235000004054 Thymus serpyllum Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000019209 bilberry extract Nutrition 0.000 description 1
- 229940102480 bilberry extract Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 238000006209 dephosphorylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000002488 outer root sheath cell Anatomy 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Description
本発明は、美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤及び毛乳頭細胞増殖促進剤に関する。 The present invention relates to a whitening agent, an anti-aging agent, a profilagrin mRNA expression increase promoter, a hair restorer and a hair papillary cell growth promoter.
皮膚においてメラニンは、紫外線から生体を保護する役目も果たしているが、過剰生成や不均一な蓄積は、皮膚の黒化やシミの原因となる。したがって、皮膚の色黒(皮膚色素沈着症)、シミ、ソバカス等を予防、治療又は改善するためには、メラニンの産生を抑制することが考えられる。 Melanin also plays a role in protecting the body from ultraviolet rays in the skin, but overproduction and uneven accumulation cause skin darkening and spots. Therefore, in order to prevent, treat, or improve skin darkness (skin pigmentation), spots, buckwheat, etc., it is conceivable to suppress the production of melanin.
このような観点から、従来、メラニン産生抑制作用を有するものとして、例えば、トウゴマ根部からの抽出物(特許文献1参照)、サウスウレア(Saussurea)属に属する植物からの抽出物(特許文献2参照)等が知られている。 From such a point of view, conventionally, as one having an inhibitory action on melanin production, for example, an extract from roots of castor bean (see Patent Document 1), an extract from a plant belonging to the genus Southus (Saussurea) (see Patent Document 2) Etc. are known.
グルタチオンは、グルタミン酸、システイン及びグリシンの3つのアミノ酸からなるトリペプチドであり、細胞内の主要なシステイン残基を有する化合物である。細胞内におけるグルタチオンは、ラジカルの捕捉、酸化還元による細胞機能の調節、各種酵素のSH供与体としての機能を果たすものであり、抗酸化成分としても知られている。その作用発現は、システイン残基に由来すると考えられている。しかしながら、皮膚中のグルタチオン量は、加齢により低下することが報告されており、このことが皮膚における酸化防御能を低下させ、細胞のDNA及びタンパク質等の構成成分にダメージを与える一因であると考えられている。 Glutathione is a tripeptide consisting of three amino acids, glutamic acid, cysteine and glycine, and is a compound having a major cysteine residue in the cell. Intracellular glutathione functions as a radical donor, regulation of cell function by redox, and an SH donor for various enzymes, and is also known as an antioxidant component. Its action expression is thought to be derived from cysteine residues. However, it has been reported that the amount of glutathione in the skin decreases with aging, and this is one factor that reduces the oxidative defense ability in the skin and damages cellular components such as DNA and proteins. It is believed that.
すなわち、皮膚においてグルタチオンの産生を促進することは、加齢により衰える酸化ストレスの防御を高め、かつ紫外線による酸化ストレスに対する障害を抑制することにつながり、皮膚の老化の予防・治療、又はシミ等の色素沈着に対する改善が期待できると考えられる。このような考えに基づき、グルタチオン産生促進作用を有するものとして、ビルベリー抽出物及びウォルナット抽出物(特許文献3参照)、クチナシ属植物の抽出物(特許文献4参照)等が知られている。 That is, promoting the production of glutathione in the skin increases the defense against oxidative stress that declines with aging and suppresses damage to oxidative stress caused by ultraviolet rays. It is considered that improvement for pigmentation can be expected. Based on such an idea, bilberry extract, walnut extract (see Patent Document 3), gardenia plant extract (see Patent Document 4), and the like are known as having glutathione production promoting action.
天然保湿因子(Natural Moisturizing Factors;NMF)の主成分であるアミノ酸は、ケラトヒアリン顆粒に由来するフィラグリンが角質層内で分解されて産生される。このフィラグリンは、角質層直下の顆粒層に存在する表皮ケラチノサイトでプロフィラグリンとして発現する。その後、直ちにリン酸化し、ケラトヒアリン顆粒に蓄積され、脱リン酸、加水分解を経てフィラグリンへと分解され、角質層に移行して、ケラチンフィラメントの凝集効率を高め、角質細胞の内部構築に関与することが知られている(非特許文献1参照)。 An amino acid which is a main component of natural moisturizing factors (NMF) is produced by degrading filaggrin derived from keratohyalin granules in the stratum corneum. This filaggrin is expressed as profilagrin in epidermal keratinocytes present in the granule layer immediately below the stratum corneum. It is then phosphorylated immediately, accumulated in keratohyalin granules, decomposed into filaggrin through dephosphorylation and hydrolysis, and then transferred to the stratum corneum, increasing the aggregation efficiency of keratin filaments and participating in the internal construction of keratinocytes It is known (see Non-Patent Document 1).
近年、このフィラグリンが、皮膚の水分保持に非常に重要かつ必要不可欠であること、及び乾燥等の条件によってフィラグリンの合成力が低下し、角質層におけるアミノ酸量が低下することが知られている(非特許文献2参照)。角質層におけるアミノ酸量が低下し、角質層の水分量が低下すると、角質層が硬くなってしまい、角質層に亀裂を生じさせ、皮膚のしわ等の原因となることが知られている。 In recent years, it has been known that this filaggrin is very important and indispensable for moisture retention of the skin, and that the synthetic power of filaggrin is reduced by conditions such as drying, and the amount of amino acids in the stratum corneum is reduced ( Non-patent document 2). It is known that when the amount of amino acid in the stratum corneum decreases and the water content of the stratum corneum decreases, the stratum corneum becomes hard, causing cracks in the stratum corneum and causing skin wrinkles and the like.
したがって、表皮ケラチノサイトにおいて、プロフィラグリンの産生促進を通じて、フィラグリンの産生を促進し、それにより角質層内のアミノ酸量を増大させることで、角質層の水分環境を本質的に改善することができ、皮膚のしわ等を防止し得ると期待されている。 Therefore, in the epidermal keratinocytes, by promoting the production of profilagrin, the production of filaggrin and thereby increasing the amount of amino acids in the stratum corneum can essentially improve the water environment of the stratum corneum. It is expected that wrinkles can be prevented.
このようなプロフィラグリン産生促進作用及びフィラグリン産生促進作用を有するものとしては、例えば、カンゾウ抽出物(特許文献5参照)、天然植物中に含まれるフラバノン配糖体として知られるリクイリチン(特許文献6参照)等が知られており、プロフィラグリン及びフィラグリン蛋白産生促進作用を有するものとしては、例えば、Citrus属に属する植物エキス又は酵母エキス(特許文献7参照)等が知られている。 As what has such a profilagulin production promotion effect and a filaggrin production promotion effect, for example, a liquorice extract (refer patent document 5), the liquiritin known as flavanone glycoside contained in a natural plant (refer patent document 6) For example, a plant extract or yeast extract belonging to the genus Citrus (see Patent Document 7) or the like is known as one having profilaggrin and filaggrin protein production promoting action.
毛髪の成長は、成長期、退行期、休止期からなる周期的なヘアサイクル(毛周期)に従って成長及び脱落を繰り返している。このヘアサイクルのうち、休止期から成長期へかけての新たな毛包が形成されるステージが、発毛に最も重要であると考えられており、このステージにおける毛包上皮系細胞の増殖・分化に重要な役割を果たしているのが、毛乳頭細胞であると考えられている。毛乳頭細胞は、毛根近傍にある外毛根鞘細胞とマトリックス細胞とからなる毛包上皮系細胞の内側にあって、基底膜に包まれている毛根の根幹部分に位置する細胞であり、毛包上皮系細胞へ働きかけてその増殖を促す等、毛髪への分化に重要な役割を担っている(非特許文献3参照)。 Hair growth repeats growth and loss according to a periodic hair cycle (hair cycle) consisting of a growth period, a regression period, and a rest period. Of these hair cycles, the stage at which new hair follicles are formed from the resting stage to the growing stage is considered to be the most important for hair growth. It is thought that hair papilla cells play an important role in differentiation. The dermal papilla cell is a cell located inside the hair follicle epithelial cell composed of outer root sheath cells and matrix cells in the vicinity of the hair root, and located in the root portion of the hair root wrapped in the basement membrane. It plays an important role in differentiation into hair, such as by acting on epithelial cells to promote their proliferation (see Non-Patent Document 3).
このように、毛乳頭細胞は、毛包上皮系細胞の増殖・分化及び毛髪の形成において最も重要な役割を果たしており、従来、毛乳頭細胞に対象物質を接触させて、その細胞の増殖活性の有無及び/又は強弱を特定することで、その対象物質の育毛効果を検定する方法が提案されている(特許文献8参照)。また、従来、毛乳頭細胞増殖促進作用を有する生薬としては、例えば、ハトムギ抽出物、ワイルドタイム抽出物、スギナ抽出物、ショウブ抽出物、ローズマリー抽出物、ウコン抽出物、シラカバ抽出物及びコウチャ抽出物等が提案されている(特許文献9参照)。 Thus, dermal papilla cells play the most important role in the proliferation and differentiation of hair follicle epithelial cells and the formation of hair. Conventionally, the target substance is brought into contact with dermal papilla cells, and the proliferation activity of the cells is controlled. A method for testing the hair-growth effect of the target substance by specifying the presence and / or strength is proposed (see Patent Document 8). Conventional herbal medicines having a dermal papilla cell growth promoting action include, for example, pearl barley extract, wild thyme extract, cedar extract, shobu extract, rosemary extract, turmeric extract, birch extract and kocha extract. A thing etc. are proposed (refer patent document 9).
本発明は、安全性の高い天然抽出物を有効成分とする美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤及び毛乳頭細胞増殖促進剤を提供することを目的とする。 An object of the present invention is to provide a whitening agent, an anti-aging agent, a profilagrin mRNA expression increase promoter, a hair restorer, and a hair papillary cell growth promoter comprising a highly safe natural extract as an active ingredient.
上記目的を達成するために、本発明の美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤又は毛乳頭細胞増殖促進剤は、琥珀熱水抽出物を有効成分として含有することを特徴とする。 In order to achieve the above object, the whitening agent, anti-aging agent, profilagulin mRNA expression increase promoter, hair restorer or hair papilla cell growth promoter of the present invention contains a hot water extract as an active ingredient. Features.
本発明の美白剤においては、前記琥珀熱水抽出物が、メラニン産生抑制作用及び/又はグルタチオン産生促進作用を有するのが好ましい。 In the whitening agent of this invention, it is preferable that the said hot water extract has a melanin production inhibitory effect and / or a glutathione production promotion effect.
本発明によれば、天然物である琥珀熱水抽出物を有効成分として含有し、安全性の高い美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤及び毛乳頭細胞増殖促進剤を提供することができる。 According to the present invention, it contains a natural hot water extract as an active ingredient, and is a highly safe whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer, and hair papillary cell proliferation promoter. Can be provided.
以下、本発明の一実施形態について説明する。
本実施形態の美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤又は毛乳頭細胞増殖促進剤は、琥珀熱水抽出物を有効成分として含有する。
Hereinafter, an embodiment of the present invention will be described.
The whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer or hair papilla cell growth promoter of this embodiment contains a hot water extract as an active ingredient.
ここで、本実施形態において「抽出物」には、琥珀を抽出原料として得られる抽出液、当該抽出液の希釈液若しくは濃縮液、当該抽出液を乾燥して得られる乾燥物、又はこれらの粗精製物若しくは精製物のいずれもが含まれる。 Here, in the present embodiment, the “extract” refers to an extract obtained by using koji as an extraction raw material, a diluted or concentrated solution of the extract, a dried product obtained by drying the extract, or a rough product thereof. Both purified products and purified products are included.
本実施形態において使用する抽出原料は、琥珀である。琥珀とは、木の樹脂(主にマツ、スギ、ヒノキ等の松柏科に属する植物の樹脂)が地中に埋没し、長い年月を経て固化したものである。上記樹脂には多量のジテルペン類が含有されていることが知られているが、当該ジテルペン類の大部分は難溶性の重合体である。琥珀は、通常、不規則な粒状、塊状、鍾乳状又は散粒状をなしており、内部に植物や昆虫の化石が混入されているものもある。色は、黄色、黄褐色又は赤黄色で、透明又は半透明であり、条痕は白色か淡黄色で松ヤニ状の光沢を有する。また、断面は、貝殻状をなしている。琥珀は、従来、その美しさから装飾品(宝石)として用いられる。硬度は2〜2.5、比重は1.05〜1.09である。琥珀は、粘土層、砂層、炭層又は堆積岩の中から産出され、バルト海沿岸、ドミニカ共和国、岩手県久慈地方等を産地とするものであり、これらの地域から容易に入手することができる。 The extraction raw material used in the present embodiment is straw. A cocoon is a resin made of wood (mainly a resin belonging to the pine family, such as pine, cedar, cypress, etc.) buried in the ground and solidified over the years. Although it is known that the resin contains a large amount of diterpenes, most of the diterpenes are hardly soluble polymers. The cocoons are usually irregular, lump, stalactite, or dusty, and some of them contain plant or insect fossils inside. The color is yellow, yellow-brown or red-yellow, transparent or translucent, and the streak is white or pale yellow and has a pine-like luster. The cross section has a shell shape. Amber is conventionally used as a decorative item (jewel) because of its beauty. The hardness is 2 to 2.5, and the specific gravity is 1.05 to 1.09. Coral is produced from clay layers, sand layers, coal beds or sedimentary rocks, and is produced from the Baltic Sea coast, Dominican Republic, Kuji region in Iwate Prefecture, etc., and can be easily obtained from these regions.
琥珀熱水抽出物は、抽出原料としての琥珀をそのまま又は粉砕し、抽出溶媒としての熱水による抽出に供することにより得ることができる。また、琥珀は、ヘキサン等の非極性溶媒による洗浄等の前処理を施してから抽出原料として使用してもよい。 The hot water extract can be obtained by pulverizing the raw material as an extraction raw material as it is, or subjecting it to extraction with hot water as an extraction solvent. The soot may be used as an extraction raw material after pretreatment such as washing with a nonpolar solvent such as hexane.
抽出溶媒として使用し得る水としては、純水、水道水、井戸水、鉱泉水、鉱水、温泉水、湧水、淡水等のほか、これらに各種処理を施したものが挙げられる。水に施す処理としては、例えば、精製、加熱、殺菌、濾過、イオン交換、浸透圧調整、緩衝化等が含まれる。したがって、本実施形態において抽出溶媒として使用し得る水には、精製水、熱水、イオン交換水、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等も含まれる。 Examples of water that can be used as the extraction solvent include pure water, tap water, well water, mineral spring water, mineral water, hot spring water, spring water, fresh water, and the like, as well as water that has been subjected to various treatments. Examples of the treatment applied to water include purification, heating, sterilization, filtration, ion exchange, osmotic pressure adjustment, buffering, and the like. Therefore, the water that can be used as the extraction solvent in this embodiment includes purified water, hot water, ion exchange water, physiological saline, phosphate buffer, phosphate buffered saline, and the like.
熱水抽出処理は、抽出原料に含まれる可溶性成分を熱水に溶出させ得る限り特に限定はされず、常法に従って行うことができる。例えば、抽出原料の5〜25倍量(質量比)の抽出溶媒である水に抽出原料を浸漬させ、通常40〜100℃、好ましくは60〜100℃の温度条件下で加熱して可溶性成分を抽出させた後、濾過して抽出残渣を除去することにより抽出液を得ることができる。得られた抽出液は、該抽出液の希釈液若しくは濃縮液、該抽出液の乾燥物、又はこれらの粗精製物若しくは精製物を得るために、常法に従って希釈、濃縮、乾燥、精製等の処理を施してもよい。 The hot water extraction treatment is not particularly limited as long as the soluble component contained in the extraction raw material can be eluted into the hot water, and can be performed according to a conventional method. For example, the extraction raw material is immersed in water, which is an extraction solvent in an amount 5 to 25 times (mass ratio) of the extraction raw material, and heated at a temperature of usually 40 to 100 ° C., preferably 60 to 100 ° C. After extraction, an extract can be obtained by filtering to remove the extraction residue. The obtained extract is diluted, concentrated, dried, purified, etc. according to a conventional method in order to obtain a diluted or concentrated solution of the extract, a dried product of the extract, or a crude purified product or a purified product thereof. Processing may be performed.
精製は、例えば、活性炭処理、吸着樹脂処理、イオン交換樹脂処理等により行うことができる。得られた抽出液はそのままでも美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤又は毛乳頭細胞増殖促進剤の有効成分として使用することができるが、濃縮液又は乾燥物としたものの方が使用しやすい。 Purification can be performed by, for example, activated carbon treatment, adsorption resin treatment, ion exchange resin treatment, or the like. The obtained extract can be used as an active ingredient of a whitening agent, an anti-aging agent, a profilagrin mRNA expression increase promoter, a hair restorer, or a hair papillary cell growth promoter, but it can be a concentrated solution or a dried product. Things are easier to use.
琥珀熱水抽出物は、特有の匂いを有しているため、その生理活性の低下を招かない範囲で脱色、脱臭等を目的とする精製を行うことも可能であるが、皮膚化粧料、頭髪化粧料等に配合する場合には大量に使用するものではないから、未精製のままでも実用上支障はない。 琥珀 Hot water extract has a peculiar smell and can be purified for the purpose of decolorization, deodorization, etc. within the range that does not cause a decrease in its physiological activity. When blended in cosmetics, etc., it is not used in large quantities, so there is no practical problem even if it is not purified.
上記のようにして得られる琥珀熱水抽出物は、美白作用、抗老化作用、プロフィラグリンmRNA発現上昇促進作用、育毛作用又は毛乳頭細胞増殖促進作用を有しているため、それぞれの作用を利用して美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤又は毛乳頭細胞増殖促進剤の有効成分として用いることができる。なお、琥珀に含まれる主要成分として、コハク酸が知られており、当該コハク酸が美白作用を有することが知られているが、上記琥珀熱水抽出物は、下記の実施例に示すように、実質的にコハク酸を含有していないため、琥珀熱水抽出物の有する美白作用(メラニン産生抑制作用、グルタチオン産生促進作用)、抗老化作用(プロフィラグリンmRNA発現上昇促進作用)、育毛作用(毛乳頭細胞増殖促進作用)等は、コハク酸により発揮されるものではないと推察される。 The scorched water extract obtained as described above has a whitening effect, an anti-aging effect, a profilagrin mRNA expression increase promoting effect, a hair growth effect or a hair papillary cell growth promoting effect, and therefore uses each action. Then, it can be used as an active ingredient of a whitening agent, an anti-aging agent, a profilagrin mRNA expression increase promoter, a hair restorer or a hair papillary cell proliferation promoter. In addition, succinic acid is known as a main component contained in koji, and it is known that the succinic acid has a whitening effect. However, the hot water extract is as shown in the following examples. Because it contains substantially no succinic acid, the whitening action (melanin production suppression action, glutathione production promotion action), anti-aging action (profilaggrin mRNA expression increase promotion action), hair growth action ( It is speculated that the dermal papilla cell proliferation promoting action) is not exhibited by succinic acid.
琥珀熱水抽出物が有する美白作用は、例えば、メラニン産生抑制作用及び/又はグルタチオン産生促進作用に基づいて発揮される。ただし、琥珀熱水抽出物が有する美白作用は、これらの作用に基づいて発揮される美白作用に限定されるものではない。 The whitening action of the hot water extract is exhibited based on, for example, a melanin production inhibitory action and / or a glutathione production promoting action. However, the whitening action of the hot water extract is not limited to the whitening action exhibited based on these actions.
琥珀熱水抽出物が有する抗老化作用は、例えば、プロフィラグリンmRNA発現促進作用に基づいて発揮される。ただし、琥珀熱水抽出物が有する抗老化作用は、この作用に基づいて発揮される抗老化作用に限定されるものではない。 The anti-aging effect of the hot water extract is exhibited based on, for example, a profilagrin mRNA expression promoting effect. However, the anti-aging effect of the hot water extract is not limited to the anti-aging action exhibited based on this action.
琥珀熱水抽出物が有する育毛作用は、例えば、毛乳頭細胞増殖促進作用に基づいて発揮される。ただし、琥珀熱水抽出物が有する育毛作用は、これらの作用に基づいて発揮される育毛作用に限定されるものではない。 The hair-growth action of the hot water extract is exhibited based on, for example, the action of promoting hair papillary cell proliferation. However, the hair-growth effect of the hot water extract is not limited to the hair-growth effect exhibited based on these effects.
なお、琥珀熱水抽出物は、メラニン産生抑制作用又はグルタチオン産生促進作用を有するため、それらの作用を利用して、メラニン産生抑制剤又はグルタチオン産生促進剤の有効成分として使用してもよい。 In addition, since a scorching water extract has a melanin production inhibitory effect or a glutathione production promotion effect, you may use those effects as an active ingredient of a melanin production inhibitor or a glutathione production promoter.
本実施形態の美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤又は毛乳頭細胞増殖促進剤は、琥珀熱水抽出物のみからなるものであってもよいし、琥珀熱水抽出物を製剤化したものであってもよい。 The whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer or hair papilla cell growth promoter of this embodiment may consist of only a hot water extract or hot water extraction. A product may be formulated.
琥珀熱水抽出物は、デキストリン、シクロデキストリン等の薬学的に許容し得るキャリアーその他任意の助剤を用いて、常法に従い、粉末状、顆粒状、錠剤状、液状等の任意の剤形に製剤化することができる。この際、助剤としては、例えば、賦形剤、結合剤、崩壊剤、滑沢剤、安定剤、矯臭剤等を用いることができる。また、琥珀熱水抽出物は、他の組成物(例えば、皮膚化粧料、頭髪化粧料等)に配合して使用することができる。 琥珀 Hot water extract is used in any dosage form such as powder, granule, tablet, liquid, etc., using a pharmaceutically acceptable carrier such as dextrin, cyclodextrin, etc. It can be formulated. In this case, as an auxiliary agent, for example, an excipient, a binder, a disintegrant, a lubricant, a stabilizer, a flavoring agent and the like can be used. The hot water extract can be used by blending with other compositions (for example, skin cosmetics, hair cosmetics, etc.).
なお、本実施形態の美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤又は毛乳頭細胞増殖促進剤は、必要に応じて、美白作用、抗老化作用、プロフィラグリンmRNA発現上昇促進作用、育毛作用又は毛乳頭細胞増殖促進作用を有する他の天然抽出物等を配合して有効成分として用いることができる。 In addition, the whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer or hair papillary cell proliferation promoter of the present embodiment, if necessary, whitening action, anti-aging action, profilagrin mRNA expression increase promotion Other natural extracts having an action, a hair-growth action or a hair papillary cell growth-promoting action can be blended and used as an active ingredient.
本実施形態の美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤又は毛乳頭細胞増殖促進剤の投与方法としては、一般に経皮投与等が挙げられるが、疾患の種類に応じて、その予防・治療等に好適な方法を適宜選択すればよい。 Examples of the method for administering the whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer or hair papillary cell growth promoter of this embodiment generally include transdermal administration, depending on the type of disease. A suitable method for the prevention / treatment or the like may be appropriately selected.
また、本実施形態の美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤又は毛乳頭細胞増殖促進剤の投与量も、疾患の種類、重症度、患者の個人差、投与方法、投与期間等によって適宜増減すればよい。 Further, the dosage of the whitening agent, anti-aging agent, profilagulin mRNA expression increase promoter, hair restorer or hair papilla cell growth promoter of this embodiment is also the type of disease, severity, individual differences of patients, administration method, What is necessary is just to increase / decrease suitably according to an administration period etc.
本実施形態の美白剤は、琥珀熱水抽出物が有するメラニン産生抑制作用及び/又はグルタチオン産生促進作用を通じて、皮膚の黒化、シミ、ソバカス等の色素沈着を予防・改善することができる。ただし、本実施形態の美白剤は、これらの用途以外にもメラニン産生抑制作用及び/又はグルタチオン産生促進作用を発揮することに意義のあるすべての用途に用いることができる。 The whitening agent of this embodiment can prevent or improve pigmentation such as skin darkening, spots, and freckles through the melanin production inhibitory action and / or glutathione production promoting action of the hot water extract. However, the whitening agent of the present embodiment can be used for all purposes that are meaningful in exhibiting a melanin production inhibitory action and / or a glutathione production promoting action in addition to these uses.
本実施形態の抗老化剤又はプロフィラグリンmRNA発現上昇促進剤は、琥珀熱水抽出物が有するプロフィラグリンmRNA発現上昇促進作用を通じて、皮膚の老化症状等を予防・改善することができる。ただし、本実施形態の抗老化剤は、これらの用途以外にもプロフィラグリンmRNA発現上昇促進作用を発揮することに意義のあるすべての用途に用いることができる。 The anti-aging agent or profilagrin mRNA expression increase promoter of the present embodiment can prevent or improve skin aging symptoms and the like through the action of promoting profilaggrin mRNA expression increase of the scorched water extract. However, the anti-aging agent of this embodiment can be used for all the uses meaningful in exhibiting the profilaggrin mRNA expression increase promotion effect besides these uses.
本実施形態の育毛剤又は毛乳頭細胞増殖促進作用は、琥珀熱水抽出物が有する毛乳頭細胞増殖促進作用を通じて、脱毛症を予防、治療又は改善することができる。ただし、本実施形態の育毛剤は、これらの用途以外にも毛乳頭細胞増殖促進作用を発揮することに意義のあるすべての用途に用いることができる。 The hair-restoring agent or dermal papilla cell proliferation promoting action of the present embodiment can prevent, treat or ameliorate alopecia through the dermal papilla cell proliferation promoting action of the scorched water extract. However, the hair-restoring agent of the present embodiment can be used for all uses other than these uses, which are meaningful for exerting the effect of promoting hair papillary cell proliferation.
なお、本実施形態の美白剤、抗老化剤、プロフィラグリンmRNA発現上昇促進剤、育毛剤又は毛乳頭細胞増殖促進剤は、ヒトに対して好適に適用されるものであるが、それぞれの作用効果が奏される限り、ヒト以外の動物に対して適用することもできる。 The whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer or hair papilla cell growth promoter of the present embodiment are suitably applied to humans, but each effect is Can be applied to animals other than humans as long as
以下、製造例及び試験例を示し、本発明を具体的に説明するが、本発明は下記の各例に何ら制限されるものではない。 Hereinafter, although a manufacture example and a test example are shown and this invention is demonstrated concretely, this invention is not restrict | limited to each following example at all.
〔製造例1〕琥珀熱水抽出物の製造
琥珀の粉砕物50gを90℃の熱水1000mL中に加え、2時間抽出し、熱時濾過した。残渣についてさらに同様の抽出処理をした。得られた抽出液を合わせて減圧下で濃縮し、さらに乾燥して琥珀熱水抽出物0.0005gを得た(試料1)。
[Production Example 1] Production of hot water extract 50 g of ground mash was added to 1000 mL of hot water at 90 ° C, extracted for 2 hours, and filtered while hot. The residue was further extracted in the same manner. The obtained extracts were combined, concentrated under reduced pressure, and further dried to obtain 0.0005 g of a scintillating water extract (Sample 1).
上記のようにして得られた琥珀熱水抽出物(試料1)及びコハク酸(和光純薬社製)について、下記の条件にて液体クロマトグラフィーを用いて分析した。琥珀熱水抽出物についての分析結果を図1に、コハク酸についての分析結果を図2に示す。 The hot water extract (sample 1) and succinic acid (manufactured by Wako Pure Chemical Industries, Ltd.) obtained as described above were analyzed using liquid chromatography under the following conditions. The analysis result about a hot water extract is shown in FIG. 1, and the analysis result about a succinic acid is shown in FIG.
<液体クロマトグラフィー条件>
製品名:Agilent 1100(Agilent Technologies社製)
固定相:Wakosil-II 5C18 HG(和光純薬工業社製)
カラム径:4.6mm
カラム長:150mm
移動相:85%リン酸バッファー
移動相流速:1.0mL/分
検出器:UV
検出波長:210nm
<Liquid chromatography conditions>
Product name: Agilent 1100 (Agilent Technologies)
Stationary phase: Wakosil-II 5C18 HG (manufactured by Wako Pure Chemical Industries, Ltd.)
Column diameter: 4.6 mm
Column length: 150mm
Mobile phase: 85% phosphate buffer Mobile phase flow rate: 1.0 mL / min Detector: UV
Detection wavelength: 210 nm
図2に示すように、上記条件にて液体クロマトグラフィーを用いて分析した場合、コハク酸のリテンションタイムは3.044minであったが、琥珀熱水抽出物(試料1)において当該リテンションタイムにピークが見られなかった。この結果から、琥珀熱水抽出物(試料1)には、コハク酸が実質的に含有されていないことが確認された。 As shown in FIG. 2, when analyzed using liquid chromatography under the above conditions, the retention time of succinic acid was 3.044 min, but peaked at the retention time in the hot water extract (sample 1). Was not seen. From this result, it was confirmed that the hot water extract (sample 1) does not substantially contain succinic acid.
〔試験例1〕B16メラノーマ細胞に対するメラニン産生抑制作用試験
製造例1により得られた琥珀熱水抽出物(試料1)について、以下のようにしてB16メラノーマ細胞に対するメラニン産生抑制作用を試験した。
[Test Example 1] Test for inhibiting melanin production on B16 melanoma cells The scorched water extract (Sample 1) obtained in Production Example 1 was tested for melanin production inhibitory action on B16 melanoma cells as follows.
B16メラノーマ細胞を、10%FBS含有ダルベッコMEMを用いて培養した後、トリプシン処理により細胞を回収した。回収した細胞を10%FBS及び1mmol/Lテオフィリン含有ダルベッコMEMで25.0×104cells/mLの細胞密度に希釈した後、48wellプレートに1wellあたり300μLずつ播種し、6時間培養した。 B16 melanoma cells were cultured using Dulbecco MEM containing 10% FBS, and then cells were collected by trypsin treatment. The collected cells were diluted with Dulbecco MEM containing 10% FBS and 1 mmol / L theophylline to a cell density of 25.0 × 10 4 cells / mL, then seeded on a 48-well plate at 300 μL per well and cultured for 6 hours.
培養終了後、10%FBS及び1mmol/Lテオフィリン含有ダルベッコMEMに試料を溶解した試料溶液(試料1,試料濃度は下記表1を参照)を各wellに300μL添加し、4日間培養した。培養終了後、各wellから培地を取り除き、1mol/LのNaOH溶液200μLを添加して超音波破砕機により細胞を破壊し、波長475nmにおける吸光度を測定してメラニン産生量とした。 After completion of the culture, 300 μL of a sample solution (Sample 1, see Table 1 below for sample concentration) in which the sample was dissolved in 10% FBS and 1 mmol / L theophylline-containing Dulbecco MEM was added to each well and cultured for 4 days. After completion of the culture, the medium was removed from each well, 200 μL of 1 mol / L NaOH solution was added, the cells were disrupted with an ultrasonic disrupter, and the absorbance at a wavelength of 475 nm was measured to obtain the amount of melanin produced.
また、単位細胞あたりのメラニン産生抑制作用を評価するために、上記と同様にして培養した後、400μLのPBS(−)で洗浄して、培養液を除去し、終濃度0.05mg/mLで10%FBS含有ダルベッコMEMに溶解したニュートラルレッドを各wellに200μL添加し、2.5時間培養した。培養後、ニュートラルレッド溶液を捨て、エタノール・酢酸溶液(エタノール:酢酸:水=50:1:49)を各wellに200μL添加し、色素を抽出した。抽出後、波長540nmにおける吸光度を測定した。 In addition, in order to evaluate the melanin production inhibitory action per unit cell, after culturing in the same manner as above, the culture solution was removed by washing with 400 μL of PBS (−), and the final concentration was 0.05 mg / mL. 200 μL of neutral red dissolved in 10% FBS-containing Dulbecco MEM was added to each well and cultured for 2.5 hours. After incubation, the neutral red solution was discarded, and 200 μL of ethanol / acetic acid solution (ethanol: acetic acid: water = 50: 1: 49) was added to each well to extract the dye. After extraction, the absorbance at a wavelength of 540 nm was measured.
さらに、空試験として、試料を添加せずに上記と同様にして培養した細胞について、波長475nmにおける吸光度及び540nmにおける吸光度を測定した。得られた結果から、下記式により単位細胞あたりのメラニン産生抑制率(%)を算出した。 Furthermore, as a blank test, the absorbance at a wavelength of 475 nm and the absorbance at 540 nm were measured for cells cultured in the same manner as described above without adding a sample. From the obtained results, the melanin production inhibition rate (%) per unit cell was calculated by the following formula.
メラニン産生抑制率(%)={1−(B/D)/(A/C)}×100
式中、Aは「試料無添加時の475nmにおける吸光度」を表し、Bは「試料添加時の475nmにおける吸光度」を表し、Cは「試料無添加時の540nmにおける吸光度」を表し、Dは「試料添加時の540nmにおける吸光度」を表す。
結果を表1に示す。
Melanin production inhibition rate (%) = {1− (B / D) / (A / C)} × 100
In the formula, A represents “absorbance at 475 nm when no sample is added”, B represents “absorbance at 475 nm when no sample is added”, C represents “absorbance at 540 nm when no sample is added”, and D represents “ The absorbance at 540 nm at the time of sample addition is expressed.
The results are shown in Table 1.
表1に示すように、琥珀熱水抽出物(試料1)はメラニン産生抑制作用を有することが確認された。 As shown in Table 1, it was confirmed that the hot water extract (sample 1) has a melanin production inhibitory effect.
〔試験例2〕B16メラノーマ細胞におけるグルタチオン産生促進作用試験
製造例1により得られた琥珀熱水抽出物(試料1)について、以下のようにしてグルタチオン産生促進作用を試験した。
[Test Example 2] Glutathione production promoting action test in B16 melanoma cells The hot water extract (sample 1) obtained in Production Example 1 was tested for glutathione production promoting action as follows.
B16メラノーマ細胞を、10%FBS含有D−MEM培地を用いて培養した後、トリプシン処理により細胞を回収した。回収した細胞を1.0×105cells/mLの細胞密度になるように10%FBS含有D−MEM培地で希釈した後、48ウェルプレートに1ウェル当たり200μLずつ播種し、一晩培養した。 B16 melanoma cells were cultured using D-MEM medium containing 10% FBS, and then cells were collected by trypsin treatment. The collected cells were diluted with 10% FBS-containing D-MEM medium to a cell density of 1.0 × 10 5 cells / mL, then seeded at 200 μL per well in a 48-well plate and cultured overnight.
培養後、1%FBS含有D−MEM培地で溶解した試料溶液(試料1,試料濃度は下記表2を参照)を各ウェルに200μL添加し、24時間培養した。培養終了後、各ウェルから培地を抜き、400μLのPBS(−)にて洗浄後、150μLのM−PER(PIERCE社製)を使用して細胞を溶解した。 After culturing, 200 μL of a sample solution dissolved in 1% FBS-containing D-MEM medium (Sample 1, see Table 2 below for sample concentration) was added to each well and cultured for 24 hours. After completion of the culture, the medium was removed from each well, washed with 400 μL of PBS (−), and cells were lysed using 150 μL of M-PER (PIERCE).
このうちの100μLを使用して総グルタチオンの定量を行った。すなわち、96ウェルプレートに溶解した細胞抽出液100μL、0.1Mのリン酸緩衝液50μL、2mMのNADPH25μL及びグルタチオンレダクターゼ25μL(終濃度17.5unit/mL)を加え37℃で10分間加温した後、10mMの5,5'-dithiobis(2-nitrobenzoic acid)25μLを加え、5分後までの波長412nmにおける吸光度を測定し、ΔOD/minを求めた。総グルタチオン濃度は、酸化型グルタチオン(和光純薬社製)を使用して作成した検量線をもとに算出した。得られた値を総タンパク量当たりのグルタチオン量に補正した後、下記式によりグルタチオン産生促進率(%)を算出した。 Of these, 100 μL was used to quantify total glutathione. That is, after adding 100 μL of cell extract dissolved in 96-well plate, 50 μL of 0.1 M phosphate buffer, 25 μL of 2 mM NADPH and 25 μL of glutathione reductase (final concentration 17.5 units / mL), the mixture was heated at 37 ° C. for 10 minutes. 25 μL of 10 mM 5,5′-dithiobis (2-nitrobenzoic acid) was added, and the absorbance at a wavelength of 412 nm until 5 minutes was measured to determine ΔOD / min. The total glutathione concentration was calculated based on a calibration curve prepared using oxidized glutathione (manufactured by Wako Pure Chemical Industries, Ltd.). After correcting the obtained value to the amount of glutathione per total protein amount, the glutathione production promotion rate (%) was calculated by the following formula.
グルタチオン産生促進率(%)=B/A×100
式中、Aは「試料無添加時の細胞中における総タンパク量当たりのグルタチオン量(対照)」を表し、Bは「試料添加時の細胞中における総タンパク量当たりのグルタチオン量」を表す。
結果を表2に示す。
Glutathione production promotion rate (%) = B / A × 100
In the formula, A represents “the amount of glutathione per total protein in the cell when no sample is added (control)”, and B represents “the amount of glutathione per total amount of protein in the cell when added to the sample”.
The results are shown in Table 2.
表2に示すように、琥珀熱水抽出物(試料1)は優れたグルタチオン産生促進作用を有することが確認された。 As shown in Table 2, it was confirmed that the hot water extract (sample 1) has an excellent glutathione production promoting action.
〔試験例3〕プロフィラグリンmRNA発現上昇促進作用試験
製造例1により得られた琥珀熱水抽出物(試料1)について、以下のようにしてプロフィラグリンmRNA発現上昇促進作用を試験した。
[Test Example 3] Profilaggrin mRNA expression increase promoting action test The hot water extract (sample 1) obtained in Production Example 1 was tested for profilagrin mRNA expression increase promoting action as follows.
正常ヒト新生児包皮表皮角化細胞(normal human epidermal keratinocyte,NHEK)を80cm2フラスコで正常ヒト表皮角化細胞長期培養用増殖培地(EpiLife-KG2)において、37℃、5%CO2−95%airの条件下で前培養し、トリプシン処理により細胞を集めた。 Normal human epidermal keratinocyte (NHEK) in a growth medium (EpiLife-KG2) for long-term culture of normal human epidermal keratinocytes in an 80 cm 2 flask at 37 ° C., 5% CO 2 -95% air The cells were precultured under the above conditions and cells were collected by trypsin treatment.
EpiLife-KG2を用いて35mmシャーレ(FALCON)に40×104cells/2mL/シャーレずつ播き、37℃、5%CO2−95%airの条件下で一晩培養した。24時間後に培養液を捨て、HEPES緩衝液1mLを加えてUV−B照射(50mJ/cm2)を行い、その後EpiLife-KG2で必要濃度に溶解した試験試料(試料1,試料濃度は下記表3を参照)を各シャーレに2mLずつ添加し、37℃、5%CO2−95%airの条件下で24時間培養した。培養後、培養液を捨て、ISOGEN(NIPPON GENE社製,Cat.no.311-02501)にて総RNAを抽出し、それぞれのRNA量を分光光度計にて測定し、200ng/μLになるように総RNAを調製した。 EpiLife-KG2 was used to seed 40 × 10 4 cells / 2 mL / dish in 35 mm dishes (FALCON) and cultured overnight at 37 ° C. and 5% CO 2 -95% air. After 24 hours, the culture solution was discarded, 1 mL of HEPES buffer was added, UV-B irradiation (50 mJ / cm 2 ) was performed, and then the test sample dissolved in EpiLife-KG2 to the required concentration (sample 1, sample concentration is shown in Table 3 below) 2 mL) was added to each petri dish and cultured at 37 ° C. under 5% CO 2 -95% air for 24 hours. After culturing, the culture solution is discarded, and total RNA is extracted with ISOGEN (NIPPON GENE, Cat. No. 311-02501), and the amount of each RNA is measured with a spectrophotometer so that it becomes 200 ng / μL. Total RNA was prepared.
この総RNAを鋳型とし、プロフィラグリン及び内部標準であるGAPDHのmRNAの発現量を測定した。検出はリアルタイムPCR装置Smart Cycler(Cepheid社)を用いて、TaKaRa SYBR PrimeScript RT-PCR Kit(Perfect Real Time,code No. RR063A)によるリアルタイム2 Step RT-PCR反応により行った。プロフィラグリンのmRNAの発現量は、試料無添加及び試料添加のそれぞれで培養した細胞から調製した総RNA標品を基にして、GAPDHの値で補正値を求め、さらに試料無添加の補正値を100とした時の試料添加の補正値を算出した。得られた結果から、下記式によりプロフィラグリンmRNA発現上昇促進率(%)を算出した。 Using this total RNA as a template, the expression level of profilaggrin and the internal standard GAPDH mRNA was measured. Detection was performed by real-time 2-step RT-PCR reaction using TaKaRa SYBR PrimeScript RT-PCR Kit (Perfect Real Time, code No. RR063A) using a real-time PCR device Smart Cycler (Cepheid). The expression level of mRNA for profilagrin is calculated based on the total RNA preparation prepared from the cells cultured with and without sample addition. The correction value of sample addition when 100 was calculated. From the obtained results, the profilaggrin mRNA expression increase promotion rate (%) was calculated by the following formula.
プロフィラグリンmRNA発現上昇抑制率(%)=A/B×100
式中Aは「試料添加時の補正値」を表し、Bは「試料無添加時の補正値」を表す。
結果を表3に示す。
Profilaggrin mRNA expression increase suppression rate (%) = A / B × 100
In the formula, A represents “correction value when sample is added”, and B represents “correction value when sample is not added”.
The results are shown in Table 3.
表3に示すように、琥珀熱水抽出物(試料1)は優れたプロフィラグリンmRNA発現上昇促進作用を有することが確認された。 As shown in Table 3, it was confirmed that the hot water extract (sample 1) has an excellent effect of promoting the increase in profilagrin mRNA expression.
〔試験例4〕毛乳頭細胞増殖促進作用試験
製造例1により得られた琥珀熱水抽出物(試料1)について、以下のようにして毛乳頭細胞増殖促進作用を試験した。
[Test Example 4] Hair papilla cell proliferation promoting action test The scorched water extract (sample 1) obtained in Production Example 1 was tested for hair papilla cell proliferation promoting action as follows.
正常ヒト頭髪毛乳頭細胞を、1%ウシ胎児血清(FBS)及び増殖添加剤を含有する毛乳頭細胞増殖培地を用いて培養した後、トリプシン処理により細胞を回収した。回収した細胞を、10%FBS含有ダルベッコMEMを用いて2.0×104cells/mLの細胞密度に希釈した後、コラーゲンコートした96wellプレートに1wellあたり100μLずつ播種し、3日間培養した。培養後、培地を抜き、試料を無血清DMEMに溶解した試料溶液(試料1,試料濃度は下記表4を参照)を各wellに200μLずつ添加し、さらに4日間培養した。 Normal human hair hair papilla cells were cultured using a hair papilla cell growth medium containing 1% fetal bovine serum (FBS) and growth additives, and then cells were collected by trypsinization. The collected cells were diluted to a cell density of 2.0 × 10 4 cells / mL using Dulbecco MEM containing 10% FBS, then seeded at 100 μL per well on a collagen-coated 96-well plate, and cultured for 3 days. After the culture, the medium was removed, and a sample solution (sample 1, refer to Table 4 below for sample concentration) dissolved in serum-free DMEM was added to each well in an amount of 200 μL, and further cultured for 4 days.
毛乳頭細胞増殖促進作用は、MTTアッセイを用いて測定した。培養終了後、培地を除き、無血清DMEMに溶解したMTT(終濃度0.4mg/mL)を、各wellに100μLずつ添加した。2時間培養した後に、細胞内に生成したブルーホルマザンを2−プロパノール100μLで抽出した。抽出後、波長570nmにおける吸光度を測定した。同時に濁度として波長650nmにおける吸光度を測定し、両者の差をもってブルーホルマザン生成量とした。なお、コントロールとして、試料溶液の代わりに無血清DMEMを添加した場合についても同様の測定を行った。得られた結果から、下記式により毛乳頭細胞増殖促進率(%)を算出した。 The dermal papilla cell proliferation promoting effect was measured using MTT assay. After completion of the culture, the medium was removed, and 100 μL of MTT (final concentration 0.4 mg / mL) dissolved in serum-free DMEM was added to each well. After culturing for 2 hours, blue formazan produced in the cells was extracted with 100 μL of 2-propanol. After extraction, the absorbance at a wavelength of 570 nm was measured. At the same time, the absorbance at a wavelength of 650 nm was measured as turbidity, and the difference between the two was used as the amount of blue formazan produced. As a control, the same measurement was performed when serum-free DMEM was added instead of the sample solution. From the obtained results, the hair papilla cell proliferation promotion rate (%) was calculated by the following formula.
毛乳頭細胞増殖促進率(%)=A/B×100
なお、式中、Aは「試料添加時の吸光度」を表し、Bは「試料無添加時の吸光度」を表す。
結果を表4に示す。
Hair papilla cell growth promotion rate (%) = A / B × 100
In the formula, A represents “absorbance when a sample is added”, and B represents “absorbance when no sample is added”.
The results are shown in Table 4.
表4に示すように、琥珀熱水抽出物(試料1)は優れた毛乳頭細胞増殖促進作用を有することが確認された。 As shown in Table 4, it was confirmed that the hot water extract (sample 1) has an excellent dermal papilla cell proliferation promoting action.
本発明の美白剤は、皮膚の色素沈着等の予防・改善に、本発明の抗老化剤及びプロフィラグリンmRNA発現上昇促進剤は、皮膚の老化の予防・改善に、本発明の育毛剤及び毛乳頭細胞増殖促進剤は、脱毛症の予防・改善に大きく貢献することができる。 The whitening agent of the present invention is used for the prevention and improvement of skin pigmentation and the like, and the anti-aging agent and the profilagrin mRNA expression increase promoter of the present invention are used for the prevention and improvement of skin aging. The papillary cell proliferation promoter can greatly contribute to the prevention and improvement of alopecia.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009087634A JP5464730B2 (en) | 2009-03-31 | 2009-03-31 | Whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer and hair papillary cell proliferation promoter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009087634A JP5464730B2 (en) | 2009-03-31 | 2009-03-31 | Whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer and hair papillary cell proliferation promoter |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010235551A JP2010235551A (en) | 2010-10-21 |
JP5464730B2 true JP5464730B2 (en) | 2014-04-09 |
Family
ID=43090237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009087634A Active JP5464730B2 (en) | 2009-03-31 | 2009-03-31 | Whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer and hair papillary cell proliferation promoter |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5464730B2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5858562B2 (en) * | 2011-05-19 | 2016-02-10 | 国立研究開発法人理化学研究所 | Endothelin-1 production inhibitor, SCF production inhibitor, melanin production inhibitor and use thereof obtained from persimmon |
JP5342076B1 (en) * | 2012-01-13 | 2013-11-13 | 株式会社アドバンジェン | Biochemical evaluation method |
JP6820645B2 (en) * | 2014-02-26 | 2021-01-27 | 共栄化学工業株式会社 | Whitening composition and cosmetics |
JPWO2017119143A1 (en) * | 2016-01-06 | 2019-03-28 | 琥珀バイオテクノロジー株式会社 | Skin external preparation |
WO2018212362A1 (en) | 2017-05-19 | 2018-11-22 | 株式会社ヤマノビューティケミカル | Agent for suppressing carbohydrate breakdown and absorption |
US20200397820A1 (en) | 2018-02-09 | 2020-12-24 | Kohaku Bio Technology Co., Ltd. | Glycerol Release Promoter |
JP2019194169A (en) * | 2018-05-02 | 2019-11-07 | 国立大学法人岩手大学 | Melanogenesis inhibitor |
JP6548797B1 (en) | 2018-08-10 | 2019-07-24 | 琥珀バイオテクノロジー株式会社 | Angiotensin I converting enzyme activity inhibitor |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4421718B2 (en) * | 1999-11-04 | 2010-02-24 | 希能 澤口 | Method for producing cocoon ingredient-containing agent |
PL347279A1 (en) * | 2001-04-24 | 2002-11-04 | Kosmetykow Pollena Ewa Sa Fab | Amber-based cosmetic and perfumery articles |
JP4768238B2 (en) * | 2004-07-01 | 2011-09-07 | 丸善製薬株式会社 | Profilagrin mRNA expression promoter |
FR2911779B1 (en) * | 2007-01-30 | 2009-04-24 | Lvmh Rech | COMPOSITION CONTAINING AMBER EXTRACT |
JP5162174B2 (en) * | 2007-07-24 | 2013-03-13 | 丸善製薬株式会社 | Hair restorer and anti-obesity agent |
-
2009
- 2009-03-31 JP JP2009087634A patent/JP5464730B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2010235551A (en) | 2010-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5464730B2 (en) | Whitening agent, anti-aging agent, profilagrin mRNA expression increase promoter, hair restorer and hair papillary cell proliferation promoter | |
JP5970148B2 (en) | Tyrosinase activity inhibitor, melanin production inhibitor, and SCF mRNA expression inhibitor | |
JP5226982B2 (en) | A topical skin preparation containing an extract of buckwheat | |
JP7426117B2 (en) | anti skin aging agent | |
JP2017114814A (en) | Cosmetics | |
JP2008285422A (en) | Dna damage inhibitor and glutathione production promoter | |
JP6437297B2 (en) | Skin external preparation or internal preparation containing an extract of sage grown by irradiating with light having a specific wavelength range | |
JP5889546B2 (en) | Hexosaminidase release inhibitor, stem cell growth factor mRNA expression increase inhibitor, hydrogen peroxide cell disorder preventive / ameliorating agent and glutathione production promoter | |
JP2010090093A (en) | Type i collagen production promotor, filaggrin production promoter, involucrin production promoter, and transglutaminase 1 production promoter | |
JP2023171950A (en) | Anti-aging agent, antioxidant, anti-inflammatory agent, and whitening agent, as well as cosmetic | |
JP2009102299A (en) | Collagen production promoter, and cosmetic and oral composition for collagen production promotion | |
JP5566733B2 (en) | Endothelin-1 mRNA expression, stem cell growth factor (SCF) mRNA expression inhibitor, basic fibroblast growth factor (bFGF) mRNA expression inhibitor, glutathione production promoter, and filaggrin production promoter | |
KR20140030346A (en) | Platelet-derived growth factor-bb production promoter, and mesenchymal stem cell production accelerator, stem cell stabilizer and dermal regenerator comprising the same | |
JP6595192B2 (en) | A skin external preparation or an internal preparation containing an extract of fenugreek cultivated by irradiation with light having a specific wavelength range. | |
JP2012162487A (en) | Whitening agent, anti-aging agent and skin cosmetic | |
US10980736B2 (en) | Coconut shell extracts, compositions containing same and uses | |
KR20110088832A (en) | Compositions comprising an extract of lemon balm for skin-whitening effect | |
KR20180050624A (en) | Method for removing chlorophyll and pigments from plant extracts | |
JP2012041276A (en) | Carbonylation inhibitor of protein, or transparency improver of skin | |
JP5566597B2 (en) | Type I collagen production promoter, adenosine triphosphate production promoter, filaggrin production promoter, melanin production inhibitor, basic fibroblast growth factor (bFGF) mRNA expression inhibitor, and skin transparency enhancer | |
JP5896618B2 (en) | Melanin production inhibitor | |
JP2012067061A (en) | Maillard reaction inhibitor and aging improving agent | |
KR20140058711A (en) | Food composition comprising a white lotus for skin health | |
JP2015221791A (en) | External or internal preparation for skin containing extract of ipomoea aquatica cultivated under irradiation with light having specific wavelength band | |
KR101749330B1 (en) | Cosmetic composition comprising extract of dendropanax cultivated with tree ear as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120302 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130515 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130522 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130722 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140115 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140120 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5464730 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |